Carla Mejia

Carla has over 12 years of experience in the pharmaceutical industry, including over 7 years at BioAgilytix. Before joining the BAL team, Carla worked for GSK and Talecris Biotherapeutics/Grifols. She has over a decade of experience working on development, validation, and sample analysis of immunogenicity ELISA and PK assays. She has extensive experience developing assays for a variety of matrices for both animal and human studies.

At BioAgilytix, Carla currently manages an FTE model team that develops, validates, and executes sample analysis for PK, ADA, and biomarker assays on multiple platforms including MSD, ELISA, and Gyros platforms. She earned her Bachelor of Science in Biochemistry from North Carolina State University.